NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Tempest Therapeutics Inc (NASDAQ: TPST)

 
TPST Technical Analysis
5
As on 1st May 2025 TPST STOCK Price closed @ 6.85 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.95 & Strong Buy for SHORT-TERM with Stoploss of 3.86 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TPSTSTOCK Price

Open 7.06 Change Price %
High 7.25 1 Day -0.26 -3.66
Low 6.61 1 Week -0.73 -9.63
Close 6.85 1 Month 6.03 735.37
Volume 34502 1 Year 3.40 98.55
52 Week High 8.05 | 52 Week Low 0.50
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
GNLN 0.01 0.00%
NVDA 111.61 2.47%
RNAZ 0.56 36.59%
LMDX 0.02 0.00%
PLUG 0.85 -2.30%
HCTI 0.27 68.75%
AKTS 0.04 0.00%
TSLA 280.52 -0.58%
LCID 2.53 0.80%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
PTPI 0.27 2600.00%
IDRA 8.64 1909.30%
LCAP 24.72 1362.72%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
ADXS 0.11 266.67%
NDRAW 0.03 200.00%
CTHR 0.25 150.00%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
SRAX 0.06 -72.73%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
TFFP 0.06 -62.50%
EGLE 25.86 -58.69%
MILEW 0.06 -53.85%
 
 
TPST
Daily Charts
TPST
Intraday Charts
Whats New @
Bazaartrend
TPST
Free Analysis
 
TPST Important Levels Intraday
RESISTANCE8.08
RESISTANCE7.69
RESISTANCE7.44
RESISTANCE7.20
SUPPORT6.50
SUPPORT6.26
SUPPORT6.01
SUPPORT5.62
 
TPST Forecast May 2025
4th UP Forecast10.38
3rd UP Forecast9.25
2nd UP Forecast8.55
1st UP Forecast7.85
1st DOWN Forecast5.85
2nd DOWN Forecast5.15
3rd DOWN Forecast4.45
4th DOWN Forecast3.32
 
TPST Weekly Forecast
4th UP Forecast9.12
3rd UP Forecast8.39
2nd UP Forecast7.94
1st UP Forecast7.49
1st DOWN Forecast6.21
2nd DOWN Forecast5.76
3rd DOWN Forecast5.31
4th DOWN Forecast4.58
 
TPST Forecast2025
4th UP Forecast21.92
3rd UP Forecast17.09
2nd UP Forecast14.1
1st UP Forecast11.11
1st DOWN Forecast2.59
2nd DOWN Forecast-0.4
3rd DOWN Forecast-3.39
4th DOWN Forecast-8.22
 
 
TPST Other Details
Segment EQ
Market Capital 77447224.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
TPST Address
TPST
 
TPST Latest News
 
Your Comments and Response on Tempest Therapeutics Inc
 
TPST Business Profile
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha, and is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company is headquartered in South San Francisco, California. Address: 7000 Shoreline Court, South San Francisco, CA, United States, 94080
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service